The United States continues to evaluate its international counternarcotics strategy, with a recent decision removing Venezuela from its list of countries deemed to have failed in meeting global drug control commitments. This development comes amidst Washington’s broader focus on enhancing cooperation with Latin American nations in the fight against drug trafficking.
Venezuela was previously identified by the U.S. as failing to fulfill its counternarcotics obligations, but the Trump administration has acknowledged progress under interim President Delcy Rodríguez. This recognition marks a significant shift in the U.S.’s assessment of Venezuela’s efforts against drug-trafficking organizations.
In contrast, Colombia remains on the U.S. list of countries that have not met their international counternarcotics obligations. The White House has indicated that Colombia, which is one of four countries listed, could see its status change if it demonstrates enhanced efforts in reducing coca cultivation, cocaine production, and dismantling drug-trafficking networks.
Colombian officials have expressed their commitment to addressing the entire drug-trafficking chain. Their strategy includes targeting illicit crops, production facilities, trafficking routes, and criminal finances, as well as engaging with international networks. This comprehensive approach aims to reduce the impact of drug trafficking in the region.
The decision to reevaluate these countries reflects Washington’s ongoing strategic engagement in Latin America, where both Venezuela and Colombia are recognized as major drug-transit or illicit drug-producing countries for the fiscal year 2027. However, with Venezuela’s removal from the list, the focus turns more sharply on Colombia’s future progress in meeting the U.S.’s international counternarcotics expectations.